Journal of Clinical Pediatrics ›› 2023, Vol. 41 ›› Issue (11): 833-838.doi: 10.12372/jcp.2023.22e1678
• Digestive System Disease • Previous Articles Next Articles
WEN Jing1, YU Yue1, YANG Chunlan1, LYU Jiayi2, SONG Xinping2, LI Yue1, ZHANG Xiaoling1, WANG Xiaodong1, LIU Sixi1()
Received:
2022-12-13
Published:
2023-11-15
Online:
2023-11-08
WEN Jing, YU Yue, YANG Chunlan, LYU Jiayi, SONG Xinping, LI Yue, ZHANG Xiaoling, WANG Xiaodong, LIU Sixi. Changes of intestinal flora in children with β-thalassemia major before and after transplantation[J].Journal of Clinical Pediatrics, 2023, 41(11): 833-838.
"
组 别 | A组(n=28) | B组(n=17) | C组(n=18) | D组(n=21) | E组(n=12) | 统计量 | P |
---|---|---|---|---|---|---|---|
年龄[M(P25~P75)]/岁 | 7.3(5.0~9.9) | 6.6(4.6~9.3) | 7.6(6.3~10.0) | 7.5(6.3~9.3) | 8.2(5.9~16.6) | H=1.98 | 0.740 |
女性[n(%)] | 8(28.6) | 5(29.4) | 5(27.8) | 4(19.0) | 4(33.3) | - | 0.9081) |
供者类型[n(%)] | - | 0.8311) | |||||
同胞全相和 | 3(10.7) | 4(23.5) | 2(11.1) | 3(14.3) | 2(16.7) | ||
无关全相和 | 0(0) | 0(0) | 1(5.6) | 1(4.8) | 0(0) | ||
单倍体 | 25(89.0) | 13(76.5) | 15(83.3) | 17(80.9) | 10(83.3) | ||
预处理方案[n(%)] | - | 0.8081) | |||||
Cy+Bu+Flu+TT+ATG | 25(89.3) | 13(76.5) | 16(88.9) | 18(85.7) | 10(83.3) | ||
Cy+CSA+Bu+Flu+TT+ATG | 3(10.7) | 4(23.5) | 2(11.1) | 3(14.3) | 2(16.7) | ||
预防GVHD[n(%)] | - | 0.8081) | |||||
CSA+MMF | 3(10.7) | 4(23.5) | 2(11.1) | 3(14.3) | 2(16.7) | ||
Pt-Cy+MMF+FK506 | 25(89.3) | 13(76.5) | 16(88.9) | 18(85.7) | 10(83.3) |
"
组 别 | A组(n=28) | B组(n=17) | C组(n=18) | D组(n=21) | E组(n=12) | H值 | P |
---|---|---|---|---|---|---|---|
厚壁菌门 | 40.7(24.1~50.9) | 21.0(6.6~38.8) | 9.9(1.1~28.2) | 18.3(13.8~25.6) | 48.6(20.4~92.0) | 20.57 | <0.001 |
变形菌门 | 73.6(2.7~15.8) | 28.3(19.0~61.8) | 43.6(14.3~80.8) | 14.3(6.2~46.1) | 3.8(0.4~54.0) | 21.01 | <0.001 |
拟杆菌门 | 44.5(27.8~52.8) | 25.4(10.3~82.7) | 0.6(0.0~39.4) | 50.1(12.9~60.7) | 0.4(0.1~39.0) | 18.46 | 0.001 |
梭菌门 | 0.1(0.0~1.5) | 0.1(0.0~18.7) | 8.0(0.1~15.3) | 0.2(0.0~20.1) | 0.0(0.0~0.0) | 11.22 | 0.024 |
放线菌门 | 0.4(0.1~13.7) | 1.0(0.3~4.1) | 0.0(0.0~0.1) | 0.1(0.0~0.3) | 0.0(0.0~0.7) | 68.27 | <0.001 |
疣状菌门 | 0.0(0.0~0.1) | 0.0(0.0~0.1) | 0.0(0.0~2.0) | 0.0(0.0~0.0) | 0.0(0.0~0.0) | 15.41 | 0.040 |
蓝菌门 | 0.0(0.0~0.0) | 0.0(0.0~2.7) | 0.0(0.0~0.0) | 0.0(0.0~0.0) | 0.0(0.0~0.2) | 42.65 | <0.001 |
[1] | 文飞球, 刘四喜. 启动重型β地中海贫血防控的攻坚战[J]. 中华儿科杂志, 2018, 56(10): 721-723. |
[2] | 广东省地中海贫血防治协会, 中国实用儿科杂志编辑委员会. 造血干细胞移植治疗重型β地中海贫血儿科专家共识[J]. 中国实用儿科杂志, 2018, 33(12): 935-939. |
[3] |
Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing[J]. Nature, 2010, 464(7285): 59-65.
doi: 10.1038/nature08821 |
[4] |
Peled JU, Gomes ALC, Devlin SM, et al. Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation[J]. N Engl J Med, 2020, 382(9): 822-834.
doi: 10.1056/NEJMoa1900623 |
[5] | 许吕宏, 方建培. 《重型β地中海贫血的诊断和治疗指南(2017年版)》解读[J]. 中国实用儿科杂志, 2018, 33(12): 940-943. |
[6] |
D'Souza A, Fretham C, Lee SJ, et al. Current use of and trends in hematopoietic cell transplantation in the United States[J]. Biol Blood Marrow Transplant, 2020, 26(8): e177-e182.
doi: 10.1016/j.bbmt.2020.04.013 |
[7] |
Penack O, Peczynski C, Mohty M, et al. How much has allogeneic stem cell transplant-related mortality improved since the 1980s? A retrospective analysis from the EBMT[J]. Blood Adv, 2020, 4(24): 6283-6290.
doi: 10.1182/bloodadvances.2020003418 pmid: 33351121 |
[8] |
Chang YJ, Pei XY, Huang XJ. Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions[J]. Lancet Haematol, 2022, 9(12): e919-e929.
doi: 10.1016/S2352-3026(22)00293-9 |
[9] |
Ruff WE, Greiling TM, Kriegel MA. Host-microbiota interactions in immune-mediated diseases[J]. Nat Rev Microbiol, 2020, 18(9): 521-538.
doi: 10.1038/s41579-020-0367-2 pmid: 32457482 |
[10] |
Lozupone CA, Stombaugh JI, Gordon JI, et al. Diversity, stability and resilience of the human gut microbiota[J]. Nature, 2012, 489(7415): 220-230.
doi: 10.1038/nature11550 |
[11] | Gałązka P, Styczyński J, Czyżewski K, et al. Impact of decontamination therapy on gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic cell transplantation in children: decontamination therapy in allo-HCT[J]. Curr Res Transl Med, 2021, 69(3): 103298. |
[12] |
Severyn CJ, Siranosian BA, Kong ST, et al. Microbiota dynamics in a randomized trial of gut decontamination during allogeneic hematopoietic cell transplantation[J]. JCI Insight, 2022, 7(7): e154344.
doi: 10.1172/jci.insight.154344 |
[13] |
Bekker V, Zwittink RD, Knetsch CW, et al. Dynamics of the gut microbiota in children receiving selective or total gut decontamination treatment during hematopoietic stem cell transplantation[J]. Biol Blood Marrow Transplant, 2019, 25(6): 1164-1171.
doi: 10.1016/j.bbmt.2019.01.037 |
[14] |
Taur Y, Xavier JB, Lipuma L, et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation[J]. Clin Infect Dis, 2012, 55(7): 905-914.
doi: 10.1093/cid/cis580 pmid: 22718773 |
[15] |
Holler E, Butzhammer P, Schmid K, et al. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease[J]. Biol Blood Marrow Transplant, 2014, 20(5): 640-645.
doi: 10.1016/j.bbmt.2014.01.030 |
[16] |
Wei L, Wen XS, Xian CJ. Chemotherapy-induced intestinal microbiota dysbiosis impairs mucosal homeostasis by modulating toll-like receptor signaling pathways[J]. Int J Mol Sci, 2021, 22(17): 9474.
doi: 10.3390/ijms22179474 |
[17] |
Rajagopala SV, Singh H, Yu Y, et al. Persistent gut microbial dysbiosis in children with acute lymphoblastic leukemia (all) during chemotherapy[J]. Microb Ecol, 2020, 79(4): 1034-1043.
doi: 10.1007/s00248-019-01448-x pmid: 31754744 |
[18] |
Yixia Y, Sripetchwandee J, Chattipakorn N, et al. The alterations of microbiota and pathological conditions in the gut of patients with colorectal cancer undergoing chemotherapy[J]. Anaerobe, 2021, 68: 102361.
doi: 10.1016/j.anaerobe.2021.102361 |
[19] | 陈森敏, 刘四喜, 陈芬, 等. 儿童急性淋巴细胞白血病化疗前后肠道菌群变化特点[J]. 中国当代儿科杂志, 2022, 24(5): 550-560. |
[20] |
Harris B, Morjaria SM, Littmann ER, et al. Gut microbiota predict pulmonary infiltrates after allogeneic hematopoietic cell transplantation[J]. Am J Respir Crit Care Med, 2016, 194(4): 450-463.
doi: 10.1164/rccm.201507-1491OC |
[21] |
Le Bastard Q, Chevallier P, Montassier E. Gut microbiome in allogeneic hematopoietic stem cell transplantation and specific changes associated with acute graft vs host disease[J]. World J Gastroenterol, 2021, 27(45): 7792-7800.
doi: 10.3748/wjg.v27.i45.7792 |
[22] |
Ingham AC, Kielsen K, Mordhorst H, et al. Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation[J]. Microbiome, 2021, 9(1): 148.
doi: 10.1186/s40168-021-01100-2 pmid: 34183060 |
[23] |
Hayase E, Hayase T, Jamal MA, et al. Mucus-degrading bacteroides link carbapenems to aggravated graft-versus-host disease[J]. Cell, 2022, 185(20): 3705-3719.
doi: 10.1016/j.cell.2022.09.007 pmid: 36179667 |
[24] | Elgarten CW, Li Y, Getz KD, et al. Broad-spectrum antibiotics and risk of graft-versus-host disease in pediatric patients undergoing transplantation for acute leukemia: association of carbapenem use with the risk of acute graft-versus-host disease[J]. Transplant Cell Ther, 2021, 27(2): 177. |
[1] | LUO Mingjing, YU Jiaming, WANG Xiaodong, ZHANG Xiaoling, YU Yue, ZHANG Yu, WEN Feiqiu, LIU Sixi. Clinical analysis of invasive fungal disease secondary to allogeneic hematopoietic stem cell transplantation in 424 children with thalassemia [J]. Journal of Clinical Pediatrics, 2025, 43(1): 21-28. |
[2] | ZHANG Yunhui, SHI Huijing, ZHAI Xiaowen. The Shanghai Maternal-Child Pairs Cohort (MCPC) and its application in clinical research [J]. Journal of Clinical Pediatrics, 2024, 42(9): 758-767. |
[3] | GUO Jiaying, ZHOU Zijing, LI Yaohua. Supervision status and clinical research of pediatric medical devices in China and the United States [J]. Journal of Clinical Pediatrics, 2024, 42(9): 822-826. |
[4] | LI Yue, ZHOU Xiaohui, WANG Xiaodong, YANG Chunlan, WANG Chunjing, ZHANG Yu, LIU Sixi. Successful treatment of massive pericardial effusion after hematopoietic stem cell transplantation with tocilizumab: two cases report [J]. Journal of Clinical Pediatrics, 2024, 42(7): 595-599. |
[5] | CHAI Xingyuan, ZHANG Zhiyong, ZHAO Xiaodong. Progress in radical treatment of X-linked severe combined immunodeficiency [J]. Journal of Clinical Pediatrics, 2024, 42(7): 659-662. |
[6] | KANG Li, HUANG Jiaoling. The impact of infectious disease outbreaks on the pediatric healthcare system and countermeasures [J]. Journal of Clinical Pediatrics, 2024, 42(6): 475-479. |
[7] | XU Lili, MA Zhushengying, QIAN Wen, XU Yaya, ZHU Yueniu, ZHU Xiaodong, GE Xiaohua. Delirium in pediatric intensive care unit with mechanical ventilation: analysis of incidence and influencing factors [J]. Journal of Clinical Pediatrics, 2024, 42(5): 445-449. |
[8] | WANG Yingjie, CHEN Zhiwei, MAI Yumiao, SUN Pan, JING Zhaohe, DONG Pengpeng, LIU Jian. Allogeneic hematopoietic stem cell transplantation for treatment of dyskeratosis congenita: a report of 3 cases and literature review [J]. Journal of Clinical Pediatrics, 2024, 42(3): 243-248. |
[9] | GUAN Liqiang, JIANG Fan, CHEN Jiao, LIU Zhouyang, SUN Yuan. Umbilical cord blood transplantation in the treatment of metachromatic leukodystrophy: a report of 3 cases [J]. Journal of Clinical Pediatrics, 2024, 42(3): 249-252. |
[10] | SUN Ruonan, LI Bohan, ZHENG Defei, ZHAO Xiaying, LIN Ziyun, HU Yixin, GAO Li, GAO Jing, LI Jie, LU Jun, XIAO Peifang, PAN Jian, LING Jing, FANG Fang, HU Shaoyan. Factors related to bronchiolitis obliterans syndrome in pediatric patients survived longer than 100 days after hematopoietic stem cell transplantation [J]. Journal of Clinical Pediatrics, 2024, 42(2): 139-145. |
[11] | WANG Bo, ZHOU Xin, SUN Jing, ZHAO Liudan, SUN Kun. Status and prospects of the children's digital research network [J]. Journal of Clinical Pediatrics, 2024, 42(2): 171-176. |
[12] | SHU Wenzhuo, MA Xiaobao, SHEN Jiali, WANG Wei, WANG Lu, SUN Jin, HE Kuan, JIN Yulian, YANG Jun, CHEN Jianyong. Reliability and validity evaluation of the Chinese version of pediatric vestibular symptom questionnaire [J]. Journal of Clinical Pediatrics, 2024, 42(12): 1001-1005. |
[13] | YAN Mei, TANG Weibing, FANG Yongjun, HUANG Jie, ZHU Ting, FU Jinyu, XIA Xiaona, LIU Changwei, WAN Yuanyuan, PAN Jian. Analysis of factors influencing dietary changes in children undergoing allogeneic hematopoietic stem cell transplantation [J]. Journal of Clinical Pediatrics, 2024, 42(11): 955-961. |
[14] | DAI Yinliang, HE Hailong, FAN Liyan, LI Jie, LU Jun, XIAO Peifang, LING Jing, ZHENG Jiajia, DU Zhizhuo, HU Shaoyan. Successful rescue of progression from Fanconi anemia to acute myeloid leukemia by allogeneic hematopoietic stem cell transplantation with decitabine maintenance: a case report [J]. Journal of Clinical Pediatrics, 2024, 42(1): 75-79. |
[15] | LIN Liangkang, LIU Zhongqiang, QIAO Lina, LI Deyuan, ZHANG Haiyang. Drug analysis of polymyxin B in the treatment of severe carbapenem-resistant Gram-negative bacteria infection in children [J]. Journal of Clinical Pediatrics, 2023, 41(8): 578-583. |
|